USB
55
-6
LLY
37
-3
LEG
36
4
ILMN
42
5
HST
49
-9
XRAY
28
2
KMB
39
2
APD
59
2
CAH
48
-5
HAS
33
3
GE
67
2
RIG
60
2
PGR
65
2
CA
38
6
CMG
72
5
MPC
44
-3
BWA
48
2
NRG
49
-3
PSA
58
2
NDAQ
62
2
USB
55
-6
LLY
37
-3
LEG
36
4
ILMN
42
5
HST
49
-9
XRAY
28
2
KMB
39
2
APD
59
2
CAH
48
-5
HAS
33
3
GE
67
2
RIG
60
2
PGR
65
2
CA
38
6
CMG
72
5
MPC
44
-3
BWA
48
2
NRG
49
-3
PSA
58
2
NDAQ
62
2
Financhill
Back

CytoMed Therapeutics 10K Form

Buy
62

GDTC
CytoMed Therapeutics

Last Price:
2.20
Seasonality Move:
-35.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GDTC News And Ratings

See the #1 stock for the next 7 days that we like better than GDTC

GDTC Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.65
Price / Book: 3.48

Profitability

EPS (TTM): -0.19340
Net Income (TTM): $-2.27M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

CytoMed Therapeutics Earnings Forecast

Key CytoMed Therapeutics Financial Ratios

  • The Interest Expense is -1.24% of Operating Income.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

CytoMed Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GDTC
Website: w2.cytomed.sg

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GDTC Technical Analysis vs Fundamental Analysis

Buy
62
CytoMed Therapeutics (GDTC) is a Buy

Is CytoMed Therapeutics a Buy or a Sell?